Carole Federico completed an MSc in Bioethics, followed by a PhD in Experimental Medicine at McGill University. Her dissertation, supervised by Jonathan Kimmelman, applied meta-analytic techniques to understand inefficiencies in the clinical translation of pain drugs. Carole's research focuses on rigor and reproducibility in biomedical science, with a special interest in the conditions of ethical animal research and how preclinical findings affect uncertainty at the transition between preclinical and clinical testing. At Stanford her work is supported by theNational Human Genome Research Institute’s Ethical Legal and Social Implications (ELSI) Program.
Daphne Martschenko PhD, is a Research Fellow at the Stanford Center for Biomedical Ethics with support from a National Human Genome Research Institute’s Ethical Legal and Social Implications (ELSI) Program training grant. Daphne received a Ph.D. in Education from the University of Cambridge in 2019 under the supervision of Anna Vignoles and Jo-Anne Dillabough. Her dissertation investigated teacher perspectives on the role and relevance of genetic data for education, focusing in particular on how behavioral genetics research on educational attainment and intelligence intersected with educators' conceptualizations of racial and socioeconomic disparities in the American education system. Currently, Daphne's work advocates for and facilitates cross-disciplinary research efforts that promote socially responsible communication of social science genomics research findings. Notable prior projects include an ‘adversarial collaborative’ effort with social science genomics researchers to explore recent developments in Genetics and Education (AERA Open, 2019) and guest editing a Special Issue devoted to the introduction of the biosocial sciences into Education (Research in Education, 2020).
Adam Omelianchuk, PhD is a Clinical Ethics Fellow at the Stanford Center for Biomedical Ethics. He received his PhD in philosophy from the University of South Carolina in 2018 and was a Lecturer in philosophy at Clemson University from 2018-2020; he also chaired the Institutional Review Board at AnMed Health Medical Center in Anderson, SC from 2019-2020. His research interests are currently focused on the biological validity of brain death declarations, the moral status of human life (even at the margins), and the ethical validity of the 'dead-donor rule' in organ transplantation. His most recent research investigates what sort of freedoms patients and their families are entitled to in light of a brain death declaration.
Vasiliki (Vaso) Rahimzadeh, PhD is an applied bioethics scholar with research interests at the intersection of precision medicine, data governance and public policy. She joins the Stanford Center for Biomedical Ethics as a Postdoctoral Fellow with support from a National Human Genome Research Institute’s Ethical Legal and Social Implications (ELSI) Program training grant. Combining deliberative democratic methods with critical policy analysis, her research broadly examines how emerging health information technologies and the regulatory regimes used to govern them can together support sharing patient data more widely, efficiently and securely. She was named a Vanier Canada Graduate Scholar for her work in this area from 2016-2019, during which time she completed her PhD jointly at the Centre of Genomics and Policy and Department of Family Medicine at McGill University. Her doctoral dissertation first developed, then validated an ethical-legal framework for the responsible sharing of genomic and associated clinical data involving children in Canada. She holds a MSc in Experimental Medicine with specialization in biomedical ethics also from McGill University, and completed a B.S. in Microbial Biology at the University of California Berkeley in 2012. In addition to her published research contributions in journals such as JAMA Pediatrics, American Journal of Bioethics and European Journal of Human Genetics, Vaso also served as a national representative for bioethics trainees on the Canadian Institutes of Health Research Standing Committee on Ethics (2017-2020), and is a member of the Regulatory and Ethics Workstream of the Global Alliance for Genomics and Health where she facilitates international policy harmonization and standards-setting for health-related data sharing.
Dr. Jennifer Young is a trained couples and family therapist working across the fields of public health, mental health, family systems, and genetics. She completed her PhD in Family Science at the University of Maryland in June 2018. Prior to receiving her doctorate, she received a BA (Psychology and Chinese) from the University of Wisconsin Madison, an MA (East Asian Languages and Literature) from The Ohio State University, an MS in Couples and Family Therapy from the University of Maryland. She recently completed a four-year fellowship at the NIH in the National Cancer Institute’s Clinical Genetics Branch where she worked as a psychosocial qualitative research specialist and mental health clinician. At the NCI, her dissertation research outlined the unique social and psychological needs of families with a Li Fraumeni Syndrome, a rare cancer predisposition syndrome. Her research focuses on advocacy for culturally competent mental health resources for families undergoing genetic testing for inherited health conditions.